Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial (Q46494654)
scientific article published in April 1990
Language:
Current Data About Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial
(P31) (Q13442814)
(P248)
(P698) 2187912
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/2187912

(P50) (Q1717451)
(P1545) 5
(P1932) JÜRGEN MARGRAF
(P248)
(P698) 2187912
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/2187912

(Q4766005)
(P1932) ANKE EHLERS
Ehlers A
(P1545) 4
(P248)
(P698) 2187912
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/2187912

(P304) 112-118
(P248)
(P698) 2187912
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/2187912

(P407) (Q1860)

(P433) 2
(P248)
(P698) 2187912
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/2187912

(P478) 10
(P248)
(P698) 2187912
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/2187912

(P577) Sunday, April 1, 1990
(P248)
(P698) 2187912
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/2187912

+1990-04-00T00:00:00Z

(P921) (Q269829)
(P887)

(Q319877)
(P887)

(Q741713)
(P887)

(Q11068)
(P887)

(Q108853737)
(P887)

(P1433) (Q6294969)
(P248)
(P698) 2187912
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/2187912

(P1476) "Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial" (language: en)
(P248)
(P698) 2187912
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/2187912

"Cardiovascular and Symptomatic Reduction Effects of Alprazolam and Imipramine in Patients with Panic Disorder: Results of a Double-Blind, Placebo-Controlled Trial" (language: en)

(P2093) Taylor CB
(P1545) 1
(P248)
(P698) 2187912
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/2187912

Hayward C
(P1545) 2
(P248)
(P698) 2187912
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/2187912

King R
(P1545) 3
(P248)
(P698) 2187912
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/2187912

Maddock R
(P1545) 6
(P248)
(P698) 2187912
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/2187912

Clark D
(P1545) 7
(P248)
(P698) 2187912
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/2187912

Roth WT
(P1545) 8
(P248)
(P698) 2187912
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/2187912

Agras WS
(P1545) 9
(P248)
(P698) 2187912
(P813) Friday, December 22, 2017
(P854) http://europepmc.org/abstract/MED/2187912

C BARR TAYLOR
(P1545) 1

CHRIS HAYWARD
(P1545) 2

ROY KING
(P1545) 3

RICHARD MADDOCK
(P1545) 6

DUNCAN CLARK
(P1545) 7

WALTON T. ROTH
(P1545) 8

W STEWART AGRAS
(P1545) 9

other details
aliases Cardiovascular and Symptomatic Reduction Effects of Alprazolam and Imipramine in Patients with Panic Disorder: Results of a Double-Blind, Placebo-Controlled Trial
description scientific article published in April 1990

External Links
(P356) 10.1097/00004714-199004000-00006
(P698) 2187912